Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

Also called NCT07107971

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07107971
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07107971. Randomized; no masking; primary purpose treatment. Start 2025-11-04 (actual); primary completion 2028-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques
Acronym
DELETE-LRP
Condition
Atheroscleroses
Condition
Cardiovascular Disease
Condition
Vulnerable Coronary Plaques
Condition
Vulnerable Plaque
Condition
Lipid-Rich Atherosclerosis of Coronary Artery
Condition
Acute Coronary Syndromes (ACS)
Intervention (Device)
Paclitaxel-eluting balloon
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (class: other)

Record details

Record id
cardio:ct-nct07107971
Content hash
cadca904f12abedf65c2771045d356f428128031c81f829b3977f5c4d48edd7e